Projects per year
Fingerprint
Collaborations and top research areas from the last five years
Projects
- 3 Finished
-
Establishment of antibody drug on non-alcoholic steatohepatitis through Met signaling.
Takahara, T. (PI)
2017/04/01 → 2020/03/31
Project: Research
-
Macrophage specific delivery of TNF-a inhibits NASH liver injury.
Takahara, T. (PI)
2014/04/01 → 2017/03/31
Project: Research
-
Explore the hepatic niche: spatiotemporal analyses of mesenchymal stem cells using live imaging technique
Takahara, T. (PI), Li, X. (CoI) & Ikeda, T. (CoI)
2011/04/01 → 2014/03/31
Project: Research
-
Wilson’s Disease Suspected to Involve a Novel Genetic Mutation of ATP7B Gene, Requiring a Differential Diagnosis with Non-alcoholic Steatohepatitis
Minemura, M., Fukuda, R., Tajiri, K., Muraishi, N., Murayama, A., Hayashi, Y., Takahara, T., Noguchi, A. & Yasuda, I., 2025, In: Internal Medicine. 64, 3, p. 375-379 5 p.Research output: Contribution to journal › Article › peer-review
Open Access -
CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer
Ueda, A., Yuki, S., Ando, T., Hosokawa, A., Nakada, N., Kito, Y., Motoo, I., Ito, K., Sakumura, M., Nakayama, Y., Ueda, Y., Kajiura, S., Nakashima, K., Harada, K., Kawamoto, Y., Komatsu, Y. & Yasuda, I., 2024/03, In: Cancers. 16, 5, 871.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Efficacy and Safety of Immune Checkpoint Inhibitor Combination Therapy for Dysphagia in Patients with Advanced Esophageal Cancer
Nakayama, Y., Ando, T., Takagi, H., Motoo, I., Ueda, Y., Sakumura, M., Kajiura, S., Takahashi, S., Shimada, S., Takashima, Y., Fujinami, H., Ogawa, K., Tamura, H., Hosokawa, A. & Yasuda, I., 2024/08, In: Journal of Clinical Medicine. 13, 16, 4806.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Supplementary Material for: Factors, including clinical trial eligibility, associated with induction of third-line treatment for advanced gastric cancer
Ando, T. (Contributor), Hosokawa, A. (Contributor), Sakumura, M. (Contributor), Motoo, I. (Contributor), Kajiura, S. (Contributor), Hirano, K. (Contributor), Miwa, T. (Contributor), Yokota, T. (Contributor), Nakada, N. (Contributor), Ueda, Y. (Contributor), Ueda, A. (Contributor), Tsukada, K. (Contributor), Ogawa, K. (Contributor), Nakaya, A. (Contributor), Teramoto, A. (Contributor), Nanjo, S. (Contributor), Mihara, H. (Contributor), Fujinami, H. (Contributor), Fujii, T. (Contributor) & Yasuda, I. (Contributor), Karger Publishers, 2022
DOI: 10.6084/m9.figshare.21101944, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Factors_including_clinical_trial_eligibility_associated_with_induction_of_third-line_treatment_for_advanced_gastric_cancer/21101944
Dataset
-
Supplementary Material for: Factors, including clinical trial eligibility, associated with induction of third-line treatment for advanced gastric cancer
Ando, T. (Contributor), Hosokawa, A. (Contributor), Sakumura, M. (Contributor), Motoo, I. (Contributor), Kajiura, S. (Contributor), Hirano, K. (Contributor), Miwa, T. (Contributor), Yokota, T. (Contributor), Nakada, N. (Contributor), Ueda, Y. (Contributor), Ueda, A. (Contributor), Tsukada, K. (Contributor), Ogawa, K. (Contributor), Nakaya, A. (Contributor), Teramoto, A. (Contributor), Nanjo, S. (Contributor), Mihara, H. (Contributor), Fujinami, H. (Contributor), Fujii, T. (Contributor) & Yasuda, I. (Contributor), Karger Publishers, 2022
DOI: 10.6084/m9.figshare.21101944.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Factors_including_clinical_trial_eligibility_associated_with_induction_of_third-line_treatment_for_advanced_gastric_cancer/21101944/1
Dataset